Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:01 AM
Ignite Modification Date:
2025-12-25 @ 3:01 AM
NCT ID:
NCT01126333
Eligibility Criteria:
Inclusion Criteria:
1. Male or female post-transplant patients who were in the Spare-the-nephron study.
2. Patients capable of understanding the purpose and risks of the study, who can give written informed consent and who are willing to participate in and comply with the study.
3. Women of child bearing potential must not be pregnant or breast-feeding.
4. Women of child bearing age must use two reliable forms of contraception simultaneously, unless they are status post bilateral tubal ligation, bilateral oophorectomy or hysterectomy. Effective contraception must be used before beginning of study drug therapy, for duration of study and for 12 weeks following the completion of study.
5. Must pass the evaluation to sign informed consent form.
Exclusion Criteria:
1. Male or female post-transplant patients who were enrolled in the Spare-the-nephron study, however dropped out during the study period.
2. Inability to pass the Evaluation to Sign Consent.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01126333
Study Brief:
Protocol Section:
NCT01126333